deoxyglucose has been researched along with Diabetic Glomerulosclerosis in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.90) | 18.7374 |
| 1990's | 10 (34.48) | 18.2507 |
| 2000's | 8 (27.59) | 29.6817 |
| 2010's | 7 (24.14) | 24.3611 |
| 2020's | 2 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Alouffi, S; Khan, MWA | 1 |
| Coward, RJ; Lay, AC | 1 |
| Bai, Y; Song, Y; Wang, Y; Yang, R | 1 |
| Nakaya, I; Nakayama, K; Nakayama, M; Soma, J; Tezuka, Y; Yahata, M | 1 |
| Gao, WY; Li, H; Liu, ZF; Ma, SB; Wang, XJ | 1 |
| Padilha, K; Pereira, AC; Rhee, EP; Tavares, G; Thadhani, RI; Titan, SMO; Venturini, G; Zatz, R | 1 |
| Koga, M | 1 |
| Hasslacher, C; Kulozik, F | 1 |
| Kim, WJ; Park, CY | 1 |
| Inaba, K; Kasuga, M; Kojima, H; Kusunoki, H; Liu, BF; Miyata, S; Miyazaki, H; Ohara, T; Suzuki, K; Uriuhara, A; Yamashita, Y | 1 |
| Li, L; Liu, D; Liu, Z; Zhang, J | 1 |
| Baynes, JW; Bleich, M; Busch, AE; Deemer, EK; Dingermann, T; Huber, J; Münch, G; Schäfer, S; Schmid, K; Somoza, V; Wihler, C | 1 |
| Beisswenger, PJ; Drummond, KS; Howell, SK; Mauer, M; Nelson, RG; Szwergold, BS | 1 |
| Egawa, S; Gu, Y; Inoue, K; Matsuno, S; Qi, M; Sakata, N; Sumi, S; Sunamura, M; Unno, M; Yamamoto, C | 1 |
| Chetyrkin, SV; Hudson, BG; Serianni, AS; Voziyan, PA; Zhang, W | 1 |
| Maeda, K; Miyazaki, T; Niimura, K; Niwa, T; Ohara, M; Takeda, N; Tatematsu, A; Tomiyama, S; Yoshizumi, H | 1 |
| Niimura, K; Niwa, T; Ohara, M; Takeda, N; Tatematsu, A; Tomiyama, S; Yoshizumi, H | 1 |
| Katsuzaki, T; Miyazaki, T; Niwa, T; Takei, Y; Tatemichi, N | 1 |
| Brosius, FC; Concepcion, LA; England, RL; Freytag, SO; Gilbert, JD; Heilig, CW; Heilig, KO; Liu, Y; Zhu, M | 1 |
| Hayase, F; Ishizaki, Y; Katsuzaki, T; Miyazaki, T; Niwa, T; Takei, Y; Tatemichi, N; Uematsu, T | 1 |
| Haneda, M; Inoki, K; Kikkawa, R; Koya, D; Maeda, S | 1 |
| Aoyama, I; Katsuzaki, T; Miyazaki, T; Niwa, T; Shimokata, K; Takayama, F; Tsukushi, S | 1 |
| Akanuma, Y | 1 |
| Bierhaus, A; Häring, HU; Lehmann, R; Nawroth, PP; Schleicher, ED | 1 |
| Li, L; Li, Y; Liu, H; Liu, Z; Zhang, J | 1 |
| Pitkänen, E; Servo, C | 1 |
| Emoto, M; Inoue, T; Morii, H; Nishizawa, Y; Tabata, T | 1 |
| Haneda, M; Kikkawa, R; Shigeta, Y; Togawa, M | 1 |
| Fink, G; Morris, JF; Sutherland, RC | 1 |
5 review(s) available for deoxyglucose and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Dicarbonyls Generation, Toxicities, Detoxifications and Potential Roles in Diabetes Complications.
Topics: Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Gene Expression Regulation; Glycation End Products, Advanced; Glyoxal; Humans; Insulin; Insulin Resistance; Isoenzymes; Lactoylglutathione Lyase; Oxidative Stress; Protein Carbonylation; Pyruvaldehyde; Signal Transduction | 2020 |
1,5-Anhydroglucitol and glycated albumin in glycemia.
Topics: Anemia; Animals; Blood Glucose; Deoxyglucose; Diabetic Nephropathies; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperuricemia; Liver Cirrhosis; Serum Albumin | 2014 |
1,5-Anhydroglucitol in diabetes mellitus.
Topics: Animals; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Hyperglycemia; Kidney; Postprandial Period | 2013 |
[Physiopathology and therapy of diabetes mellitus].
Topics: Animals; Arteriosclerosis; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Insulin Resistance; Obesity; Patient Education as Topic | 1999 |
Chemistry and pathobiology of advanced glycation end products.
Topics: Aging; Deoxyglucose; Diabetes Mellitus; Diabetic Nephropathies; Gene Expression Regulation; Glucose; Glycation End Products, Advanced; Glycoproteins; Glycosylation; Glyoxal; Humans; Kidney Glomerulus; Lipid Peroxidation; NF-kappa B; Oxidative Stress; Pyruvaldehyde; Reactive Oxygen Species | 2001 |
1 trial(s) available for deoxyglucose and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics.
Topics: Albuminuria; Biomarkers; Brazil; Creatinine; Deoxyglucose; Diabetic Nephropathies; Double-Blind Method; Gas Chromatography-Mass Spectrometry; Humans; Metabolomics | 2018 |
23 other study(ies) available for deoxyglucose and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
An In Vitro Method to Analyze Glucose Uptake in Podocytes.
Topics: Cell Culture Techniques; Cell Line; Deoxyglucose; Diabetic Nephropathies; Feasibility Studies; Glucose; Humans; Insulin; Insulin Resistance; Podocytes; Tritium | 2020 |
Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker In Diabetes with Earlier Chronic Kidney Disease Stages.
Topics: Adult; Aged; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Renal Insufficiency, Chronic; Uric Acid | 2019 |
Methylglyoxal as a prognostic factor in patients with chronic kidney disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Deoxyglucose; Diabetic Nephropathies; Disease Progression; Female; Humans; Japan; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyruvaldehyde; Renal Insufficiency, Chronic; Risk Factors; Time Factors; Up-Regulation | 2019 |
Elevated levels of α-dicarbonyl compounds in the plasma of type II diabetics and their relevance with diabetic nephropathy.
Topics: Aged; Biomarkers; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diacetyl; Female; Glyoxal; Humans; Male; Middle Aged; Pyruvaldehyde | 2019 |
Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
Topics: Aged; Albuminuria; Alpha-Globulins; Biomarkers; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Regression Analysis; Renal Insufficiency, Chronic; Serum Albumin; Severity of Illness Index | 2016 |
Relation between serum 3-deoxyglucosone and development of diabetic microangiopathy.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Biomarkers; Chromatography, High Pressure Liquid; Deoxyglucose; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Fasting; Glycated Hemoglobin; Glycosylation; Humans; Middle Aged; Platelet Activating Factor; Reference Values | 2003 |
Identification of glucose transporter-1 and it's functional assay in mouse glomerular mesangial cells cultured in vitro.
Topics: Animals; Cells, Cultured; Deoxyglucose; Diabetic Nephropathies; Glomerular Mesangium; Glucose Transporter Type 1; Mice; Mice, Inbred C57BL; Monosaccharide Transport Proteins; RNA, Messenger | 2001 |
Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Ascorbic Acid; Blood Glucose; Chromatography, High Pressure Liquid; Creatine; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glycated Hemoglobin; Glycation End Products, Advanced; Heterocyclic Compounds, 3-Ring; Kidney; Lysine; Male; Oxidation-Reduction; Protease Inhibitors; Ramipril; Rats; Rats, Zucker; Spectrometry, Fluorescence | 2005 |
Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress.
Topics: Adolescent; Adult; Cohort Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Susceptibility; Glycated Hemoglobin; Humans; Indians, North American; Oxidative Stress; Pyruvaldehyde; Risk Factors | 2005 |
Hyperglycemia and diabetic renal change in a model of polyvinyl alcohol bioartificial pancreas transplantation.
Topics: Animals; Bioartificial Organs; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gels; Glomerular Mesangium; Hyperglycemia; Insulin; Islets of Langerhans; Kidney Function Tests; Linear Models; Male; Mice; Mice, Inbred C57BL; Pancreas Transplantation; Pancreas, Artificial; Polyvinyl Alcohol; Rats; Rats, Wistar; Severity of Illness Index; Time Factors; Tissue Culture Techniques; Tissue Engineering; Transplantation, Heterologous | 2007 |
Pyridoxamine protects proteins from functional damage by 3-deoxyglucosone: mechanism of action of pyridoxamine.
Topics: Animals; Cattle; Cell Adhesion; Cell Line, Transformed; Collagen Type IV; Deoxyglucose; Diabetic Nephropathies; Glycosylation; Humans; Magnetic Resonance Spectroscopy; Mesangial Cells; Mice; Pyridoxamine; Ribonuclease, Pancreatic; Spectrometry, Mass, Electrospray Ionization; Sugar Acids | 2008 |
Elevated serum levels of 3-deoxyglucosone, a potent protein-cross-linking intermediate of the Maillard reaction, in uremic patients.
Topics: Adult; Aged; Blood Proteins; Cross-Linking Reagents; Deoxyglucose; Diabetic Nephropathies; Female; Gas Chromatography-Mass Spectrometry; Humans; In Vitro Techniques; Maillard Reaction; Male; Middle Aged; Muramidase; Uremia | 1995 |
Presence of 3-deoxyglucosone, a potent protein crosslinking intermediate of Maillard reaction, in diabetic serum.
Topics: Adult; Aged; Biomarkers; Cross-Linking Reagents; Deoxyglucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Gas Chromatography-Mass Spectrometry; Humans; Maillard Reaction; Male; Middle Aged; Reference Values | 1993 |
Serum levels of 3-deoxyglucosone and tissue contents of advanced glycation end products are increased in streptozotocin-induced diabetic rats with nephropathy.
Topics: Animals; Antibodies, Monoclonal; Body Weight; Creatinine; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Kidney; Male; Proteinuria; Rats; Rats, Wistar; Urea | 1996 |
D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: implications for diabetic nephropathy.
Topics: Animals; Blotting, Northern; Cell Line, Transformed; Deoxyglucose; Diabetic Nephropathies; Dose-Response Relationship, Drug; Glomerular Mesangium; Glucose; Glucose Transporter Type 1; Immunoblotting; Insulin-Like Growth Factor I; Monosaccharide Transport Proteins; Rats; Rats, Inbred F344; RNA, Messenger; Time Factors; Tritium | 1997 |
Imidazolone, a novel advanced glycation end product, is present at high levels in kidneys of rats with streptozotocin-induced diabetes.
Topics: Animals; Antibodies, Monoclonal; Arginine; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glycation End Products, Advanced; Imidazoles; Kidney; Kinetics; Maillard Reaction; Male; Mice; Rats; Rats, Wistar | 1997 |
TGF-beta 1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells.
Topics: 3-O-Methylglucose; Animals; Antibodies; Antimetabolites; Biological Transport; Cells, Cultured; Cycloheximide; Cytochalasin B; Deoxyglucose; Diabetic Nephropathies; Extracellular Matrix; Gene Expression; Glomerular Mesangium; Glucose; Glucose Transporter Type 1; Kinetics; Male; Monosaccharide Transport Proteins; Neutralization Tests; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta | 1999 |
Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway.
Topics: Adult; Aged; Aldehyde Reductase; Arginine; Creatinine; Deoxyglucose; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Female; Glycation End Products, Advanced; Hemoglobins; Humans; Imidazoles; In Vitro Techniques; Lysine; Male; Middle Aged; Polymers; Renal Dialysis; Sorbitol; Uremia | 1999 |
[Regulation of the expression and function of glucose transporter-1 by TGF-beta 1 and high glucose in mesangial cells].
Topics: Animals; Cell Line; Deoxyglucose; Diabetic Nephropathies; Glomerular Mesangium; Glucose; Glucose Transporter Type 1; Mice; Mice, Inbred C57BL; Monosaccharide Transport Proteins; RNA, Messenger; Transforming Growth Factor beta | 2000 |
Variation in polyol levels in cerebrospinal fluid and serum in diabetic patients.
Topics: Aged; Blood Glucose; Creatinine; Deoxyglucose; Diabetes Mellitus; Diabetic Nephropathies; Ethers, Cyclic; Glucose; Humans; Inositol; Insulin; Middle Aged; Sorbitol; Sugar Alcohols; Uremia | 1975 |
Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
Topics: Adult; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Kidney Failure, Chronic; Middle Aged; Renal Dialysis | 1992 |
[Metabolic and mitogenic effects of insulin-like growth factor I on rat glomerular mesangial cells cultured under high concentration of glucose].
Topics: Aminoisobutyric Acids; Animals; Cells, Cultured; Culture Media; Deoxyglucose; Diabetic Nephropathies; Glomerular Mesangium; Hyperglycemia; Insulin-Like Growth Factor I; Male; Mitosis; Rats; Rats, Inbred Strains; Thymidine | 1991 |
Effects of water deprivation and deamino [8-D-arginine] vasopressin on [14C]2-deoxyglucose uptake by the hypothalamo-hypophysial system in mice with hereditary nephrogenic diabetes insipidus.
Topics: Animals; Arginine Vasopressin; Autoradiography; Brain; Deamino Arginine Vasopressin; Deoxy Sugars; Deoxyglucose; Diabetes Insipidus; Diabetic Nephropathies; Female; Hypothalamo-Hypophyseal System; Injections, Intraperitoneal; Male; Mice; Mice, Mutant Strains; Species Specificity; Water Deprivation | 1985 |